Literature DB >> 12378528

Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.

Ioannis Panagopoulos1, Fredrik Mertens, Margareth Isaksson, Henryk A Domanski, Otte Brosjö, Sverre Heim, Bodil Bjerkehagen, Raf Sciot, Paola Dal Cin, Jonathan A Fletcher, Christopher D M Fletcher, Nils Mandahl.   

Abstract

Extraskeletal myxoid chondrosarcoma (EMC) is a soft-tissue neoplasm cytogenetically characterized by the translocations t(9;22)(q22;q11-12) or t(9;17)(q22;q11), generating EWS/CHN or RBP56/CHN fusion genes, respectively. In the present study, 18 EMCs were studied both cytogenetically and at the molecular level. Chromosomal aberrations were detected in 16 samples: 13 with involvement of 9q22 and 22q11-12, and three with rearrangements of 9q22 and 17q11. Fifteen cases had an EWS/CHN fusion transcript and three had an RBP56/CHN transcript. The most frequent EWS/CHN transcript (type 1; 10 tumors), involved fusion of EWS exon 12 with CHN exon 3, and the second most common (type 5; two cases) was fusion of EWS exon 13 with CHN exon 3. In all tumors with RBP56/CHN fusion, exon 6 of RBP56 was fused to exon 3 of CHN. By genomic XL PCR and sequence analyses, the breakpoints from 14 cases were mapped in the EWS, RBP56, and CHN genes. In CHN, 12 breakpoints were found in intron 2 and only two in intron 1. In EWS, the breaks occurred in introns 7 (one break), 12 (eight breaks), and 13 (one break), and in RBP56 in intron 6. Repetitive elements such as Alu and LINE sequences seem to have limited, if any, importance in the genesis of EWS/CHN and RBP56/CHN chimeras. Furthermore, there were no chi, chi-like, topoisomerase II, or translin consensus sequences in the introns harboring the translocation breakpoints, nor could the number of topo I sites in EWS, RBP56, and CHN introns explain the uneven distribution of the breakpoints among EWS or CHN introns. Additional genetic events, such as nucleotide insertions, homologies at the junction, deletions, duplications, and inversions, were found to accompany the translocations, indicating that the chromosomal translocations do not require sequence-specific recombinases or extensive homology between the recombined sequences. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378528     DOI: 10.1002/gcc.10127

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  22 in total

1.  Extraskeletal myxoid chondrosarcoma: a case report of complete remission by chemotherapy and review of the literature.

Authors:  Kun Han; Yuan-Jue Sun; Zan Shen; Jian-Jun Zhang; Feng Lin; Hui Zhao; Saleem Meerani; Yang Yao
Journal:  BMJ Case Rep       Date:  2010-02-08

2.  Extraskeletal myxoid chondrosarcoma of the thigh with a t(9;17) translocation.

Authors:  Taketoshi Yasuda; Takeshi Hori; Kayo Suzuki; Masahiko Kanamori; Shigeharu Nogami; Yasuhito Yahara; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2011-12-19       Impact factor: 2.967

Review 3.  Molecular pathology of chondroid neoplasms: part 2, malignant lesions.

Authors:  W C Bell; M J Klein; M J Pitt; G P Siegal
Journal:  Skeletal Radiol       Date:  2006-10-18       Impact factor: 2.199

Review 4.  The benefits of molecular pathology in the diagnosis of musculoskeletal disease : part I of a two-part review: soft tissue tumors.

Authors:  Adrienne M Flanagan; David Delaney; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2010-02       Impact factor: 2.199

Review 5.  The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.

Authors:  Jordan A Beard; Alexa Tenga; Taosheng Chen
Journal:  Cell Signal       Date:  2014-11-15       Impact factor: 4.315

6.  Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation.

Authors:  Jennifer Worch; Jobin Cyrus; Robert Goldsby; Katherine K Matthay; John Neuhaus; Steven G DuBois
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-06       Impact factor: 4.254

7.  Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy.

Authors:  Alex D Drilon; Sanjay Popat; Gauri Bhuchar; David R D'Adamo; Mary Louise Keohan; Cyril Fisher; Cristina R Antonescu; Samuel Singer; Murray F Brennan; Ian Judson; Robert G Maki
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

Review 8.  Genomic characteristics of soft tissue sarcomas.

Authors:  Fredrik Mertens; Ioannis Panagopoulos; Nils Mandahl
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

9.  Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.

Authors:  Navid Sadri; Julieta Barroeta; Svetlana D Pack; Zied Abdullaev; Bishwanath Chatterjee; Raghunath Puthiyaveettil; John S Brooks; Frederic G Barr; Paul J Zhang
Journal:  Virchows Arch       Date:  2014-07-04       Impact factor: 4.064

Review 10.  Soft tissue tumors associated with EWSR1 translocation.

Authors:  Salvatore Romeo; Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.